What Trinity Pharma does

Trinity Pharma is a privately-held, South Africa-based pharmaceutical distributor and marketer headquartered in Sandton, Gauteng. The company supplies prescription medications, over-the-counter (OTC) products, injectables, and consumer health products — including the Sebamed skincare brand — to hospitals, pharmacies, and physician-led healthcare environments across South Africa, Namibia, Botswana, Eswatini, and Lesotho. Its commercial portfolio spans more than 120 molecules and over 250 SKUs covering most therapeutic areas, with a pipeline of additional products pending registration with the South African Health Products Regulatory Authority (SAHPRA).

The company does not manufacture; it sources finished pharmaceutical products from manufacturing partners approved by stringent global regulators including the US FDA, the UK MHRA, and Australia's TGA, and registers them locally with SAHPRA. Trinity Pharma is controlled by two strategic shareholders: Strides Pharma Sciences (an Indian-headquartered global pharmaceutical group) and Juno Pharmaceuticals South Africa (Pty) Ltd. Despite operating a 250+ SKU, multi-country distribution business, the company runs on a notably lean operating model with only 1–10 employees, suggesting outsourced sales, regulatory, and logistics functions. Go-to-market is sales-led, relying on direct distribution into healthcare provider networks and a corporate website plus LinkedIn and Facebook presence for top-of-funnel engagement; pricing is not publicly disclosed.

Revenue is generated through one-time sales of pharmaceutical and consumer health products across prescription, OTC, injectable, and consumer (Sebamed) categories. The business model is a branded-generic and specialty distribution play, leveraging parent-group manufacturing scale (via Strides) and local registration expertise to serve healthcare providers and patients in Southern African markets.

Name

Trinity Pharma

Legal name

Trinity Pharma

Website

https://trinitypharma.co.za

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Trinity Pharma is a South Africa-based pharmaceutical distributor and marketer supplying 250+ prescription, OTC, injectable, and consumer health SKUs to hospitals, pharmacies, and physicians across five Southern African markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Pharmaceutical distribution
• Prescription medications
• Over-the-counter medicines
• Injectable pharmaceuticals
• Consumer healthcare products

Headquarters

HQ city

Bryanston

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Trinity Pharma generates revenue through the sale of prescription medications, over-the-counter (OTC) products, injectables, and consumer health products (including Sebamed). The company offers a portfolio of over 120 different molecules and more than 250 SKUs spanning most therapeutic areas.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Trinity Pharma distributes and markets a portfolio of pharmaceutical products in Southern Africa, comprising prescription medications, over-the-counter (OTC) products, injectable pharmaceuticals, and consumer healthcare products including the Sebamed skincare and wellness range. The portfolio spans more than 120 different molecules and over 250 SKUs across most therapeutic areas, with products sourced from manufacturing partners approved by the FDA, MHRA, TGA, and SAHPRA. The company supplies healthcare providers (hospitals, pharmacies, physicians) and consumers through established distribution channels in South Africa, Namibia, Botswana, Eswatini, and Lesotho.

Product overview

Trinity Pharma is a South African-based pharmaceutical company offering a substantial product portfolio featuring over 120 different molecules and more than 250 SKUs spanning most therapeutic areas. The company's offerings are organized into three main product categories: Prescription Medications (including branded generics like Allermine Tablets, Mucotrin, Goutack, and Lyrecol 5%), OTC Products (including Schedule 0 constipation treatments like Pholipeg, Schedule 1 allergy and respiratory products like Mucotrin and Allermine, and Schedule 2 cold/flu and cardiovascular products like Flulez and Trinprin 100), and Injectables for hospital, physician-led, and retail pharmacy settings. Additionally, the company distributes consumer products including Sebamed skincare. The portfolio also includes gastroenterology products such as Fluxtrin OTC (esomeprazole) and Pantor (pantoprazole), antifungal treatments like Lyrecol 5%, allergy medications including Fexogen, Lorano, Xyleve, and Basmedene, emergency contraception such as Lornestin, and various other therapeutic agents. Trinity Pharma has an extensive pipeline pending registration with SAHPRA with regular new launches planned.

Differentiator

Problem solved

Functional benefit

Products and services

• Prescription Medications Prescription pharmaceutical products spanning most therapeutic areas, formulated for patients across global markets and designed to address varied and changing medical needs through unique formulations and generic medicines. Prescribed and dispensed by physicians and pharmacists via hospitals, pharmacies, and physician-led practices.
• OTC Products Over-the-counter medicines organised by regulatory schedule (Schedule 0, Schedule 1, Schedule 2) including constipation treatments, allergy and respiratory products, gastrointestinal medications (e.g., pantoprazole, esomeprazole), and cardiovascular products (e.g., low-dose aspirin). Sold through pharmacies and consumer retail channels without prescription.
• Injectables Injectable pharmaceutical products supplied for administration in hospital settings, physician-led environments, and retail pharmacies across Southern Africa. Includes ready-to-administer injectables across the company's therapeutic portfolio, sourced from FDA, MHRA, TGA, and SAHPRA-approved manufacturing partners.
• Sebamed Consumer Healthcare Products Consumer healthcare products including Sebamed-branded skincare and wellness items marketed to end consumers in Southern Africa. Distributed through retail channels and the dedicated Sebamed consumer portal (sebamed.co.za).

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• FDA-Approved Manufacturing PartnerscoreTechnology or IntegrationManufacturing partners approved by the USA's FDA, UK's MHRA, Australia TGA, and SAHPRA ensuring all products meet the highest standards of safety, efficacy, and consistency.
• MHRA-Approved Manufacturing PartnerscoreTechnology or IntegrationManufacturing partners approved by the UK's MHRA, USA's FDA, Australia TGA, and SAHPRA ensuring all products meet the highest standards of safety, efficacy, and consistency.
• TGA-Approved Manufacturing PartnerscoreTechnology or IntegrationManufacturing partners approved by Australia's TGA, USA's FDA, UK's MHRA, and SAHPRA ensuring all products meet the highest standards of safety, efficacy, and consistency.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Aspen Pharmacare: Largest South African pharmaceutical company, distributing branded, generic, and consumer health products across SA and broader Africa. Directly comparable as a diversified pharma distributor/marketer serving the same healthcare provider and pharmacy channels.
• Adcock Ingram: Major South African pharmaceutical manufacturer and distributor of prescription, OTC, hospital, and consumer health products. Directly comparable across Trinity's core product categories and distribution to pharmacies, hospitals, and physicians.
• Cipla South Africa (Cipla Medpro): South African arm of Indian generics giant Cipla, distributing a broad Rx and OTC portfolio through similar pharmacy and hospital channels. Closely comparable given Indian multinational shareholder backing structure analogous to Trinity's Strides affiliation.
• ACINO South Africa (formerly Litha Healthcare): Pharmaceutical marketing and distribution company focused on Southern Africa following the merger of Litha Healthcare (where Trinity's director Selwyn Kahanovitz was formerly CEO). Highly comparable given overlapping leadership pedigree and product/market overlap.
• Pharma Dynamics (Lupin subsidiary): South African generics company and subsidiary of India's Lupin, distributing prescription and OTC medicines through pharmacies and hospitals. Comparable as an Indian-multinational-backed generics distributor operating in the same channels Trinity serves.
• Dr. Reddy's South Africa: South African operations of Indian generics multinational Dr. Reddy's Laboratories, distributing affordable Rx and OTC products to healthcare providers. Comparable as an India-headquartered generics competitor with similar strategic positioning in the SA market.

Broad incumbents

• Viatris South Africa (formerly Mylan): South African arm of global generics and specialty pharma major Viatris (formed from Mylan-Upjohn merger). Comparable as a large-scale pharmaceutical distributor serving the same healthcare provider base, though with a broader international portfolio.
• Sanofi South Africa: South African operations of global pharmaceutical major Sanofi, distributing prescription, vaccines, and consumer health products. Comparable as a broad-incumbent pharma company distributing through the same pharmacy and hospital channels Trinity serves.
• AstraZeneca South Africa: South African subsidiary of global biopharmaceutical major AstraZeneca, distributing branded prescription medicines across multiple therapeutic areas. Comparable as a multinational pharma incumbent serving overlapping physician and pharmacy channels.
• Novartis South Africa: South African operations of global pharma major Novartis, distributing innovative and generic pharmaceuticals through healthcare providers. Comparable as a broad-incumbent pharma distributor serving overlapping hospital, pharmacy, and prescriber channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/trinity-pharma-pty-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trinity Pharma